Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Efficacy and toxicity of factor Xa inhibitors

Class:Id	LiteratureReference:9603677
_displayName	Efficacy and toxicity of factor Xa inhibitors
_timestamp	2018-03-23 10:09:08
author	[Person:9603672] Bondarenko, Maryna [Person:9603674] Curti, Christophe [Person:9603676] Montana, Marc [Person:9603678] Rathelot, Pascal [Person:9603673] Vanelle, Patrice
created	[InstanceEdit:9603675] Jassal, Bijay, 2018-03-23
journal	J Pharm Pharm Sci
pages	74-88
pubMedIdentifier	23683607
title	Efficacy and toxicity of factor Xa inhibitors
volume	16
year	2013
(literatureReference)	[Summation:140679] Factor Xa (FXa), a cleavage product of coagulation factor X ... [ChemicalDrug:9603671] eribaxaban [extracellular region] [RegulationReference:9735230] Negative regulation by 'factor Xa:Factor Xa inhibitors [plasma membrane]' Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor [Reaction:9015111] Factor Xa inhibitors binds Xa [Homo sapiens] [Reaction:9015122] Factor Xa inhibitors bind Va:Xa [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Efficacy and toxicity of factor Xa inhibitors (9603677)